Glutamate/Ketamine Study

The TReAD Lab is currently conducting research investigating neuroimaging markers of response to ketamine.

One aim of this study is to examine how brain functioning and depressive symptoms change after a single administration of ketamine. Participants will undergo functional Magnetic Resonance Imaging (fMRI) scans throughout the multi-week study.

Would this study be a good fit?

This study might be a good fit if you are:

  • Between the ages of 18-65

  • Right-handed

  • Willing and able to complete fMRI scans

  • Fulfill one of the following criteria:

    • Currently experiencing a depressive episode

    • Not diagnosed with any mood disorders

  • Not taking psychotropic medications

 What does the study entail?

  • Screening visit(s)

  • One infusion of study drug or placebo

  • Multiple follow-up visits

  • Five MRI scans

  • Compensation is provided for your time

PARTICIPATE